URS
NVAX icon

Utah Retirement Systems’s Novavax NVAX Stock Holding History

Utah Retirement Systems’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,600
Closed -$140K – 991
2022
Q4 		$140K Hold
13,600
– – ﹤0.01% 939
2022
Q3 		$248K Buy
13,600
+100
+0.7% +$4.33K ﹤0.01% 894
2022
Q2 		$695K Hold
13,500
– – 0.01% 781
2022
Q1 		$995K Sell
13,500
-200
-1% -$17.8K 0.01% 757
2021
Q4 		$1.96M Buy
13,700
+400
+3% +$68.7K 0.02% 591
2021
Q3 		$2.76M Buy
13,300
+9,500
+250% +$2.09M 0.04% 464
2021
Q2 		$807K Buy
+3,800
New +$696K 0.01% 814

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Utah Retirement Systems's NVAX Position: Q1 2023 in Review

Utah Retirement Systems sold out of Novavax (NVAX) in Q1 2023, closing a stake of 13,600 shares — an estimated $140K sold.

Utah Retirement Systems first reported a position in NVAX in Q2 2021 and held it in 7 quarters. The position peaked at $2.76M in Q3 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Utah Retirement Systems reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Utah Retirement Systems sold 13,600 Novavax shares in Q1 2023, an estimated $140K.
  • Utah Retirement Systems first reported a position in Novavax in Q2 2021 and held it in 7 quarters.
  • Utah Retirement Systems's Novavax position peaked at $2.76M in Q3 2021.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Utah Retirement Systems's 13F filing for Q1 2023, filed 16 May 2023.